Chronic Heart Failure Market to Observe Stunning Growth at a CAGR of 10% by 2034 Owing to Strong Uptake of Entresto and approved SGLT2 Inhibitors along with Emergence of New Class of Therapies | DelveInsight

Several leading classes of therapies are exploring diverse mechanisms of action to treat CHF, including SGLT2 inhibitors, cardiac myosin activators, myeloperoxidase inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, cell therapies, and more. This growing focus is expected to drive the chronic heart failure market forward. In summary, the existing blockbuster therapies such as Entresto, recently […]

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Micron Technology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MU

(NASDAQ:MU), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Micron Technology, Inc. (NASDAQ: MU) between September 28, 2023 and December 18, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. SO WHAT:

Topaz Labs’ Gigapixel iOS debuts, hits App Store Top 10 in first day

For the first time ever, users can now enhance photos using AI on their phone, for free. This is part of Topaz Labs' new mobile app,Gigapixel iOS, which allows users to recover faces, restore detail, fix focus, and upscale photos from their camera roll using AI. Unlike any other AI image editing app, Gigapixel iOS'

Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The high and growing incidence of tuberculosis (TB) cases globally, especially in high-burden countries, is a major driver for both the treatment drugs and diagnostics markets. TB remains a significant public health challenge, with millions of new cases reported each year, particularly in regions with limited access to healthcare and effective diagnostics. DelveInsight's 'Tuberculosis Pipeline

Martin Guitar and Billy Strings Team Up for Signature D-28 and X Series Models

Martin Guitar is thrilled to unveil two all-new signature models at The 2025 NAMM Show-the D-28 Billy Strings and the D-X2E Billy Strings. https://mma.prnewswire.com/media/2603756/CF_Martin_and_Co_Billy_Strings_with_Martin_Guitar.jpg Joining other new releases from Martin, including the refreshed Standard Series, D-3 Millionth milestone acoustics, and more, these guitarsare crafted to capture the distinctive sound, style, and electrifying energy of GRAMMY®-winning

Fidelity Investments Canada ULC Announces Cash Distributions for Certain Fidelity ETFs and ETF Series of Fidelity Mutual Funds

Fidelity Investments Canada ULC today announced the January 2025 cash distributions for Fidelity ETFs (“Fidelity ETFs”) and ETF Series of the Fidelity mutual fund (“Fidelity Fund”) listed below. For Fidelity ETFs, unitholders of record as of January 29, 2025 will receive a per-unit cash distribution payable on January 31, 2025, as detailed in the table

Richmond American Announces Community Debut in Manor

Whisper Valley boasts a desirable location, impressive amenities and beautiful new homes Richmond American Homes of Texas, Inc., a subsidiary of M.D.C. Holdings, Inc., is pleased to announce the Grand Opening of Whisper Valley (RichmondAmerican.com/WhisperValley) in Manor. This highly anticipated new community showcases a selection of single- and two-story floor plans from the builder's popular

Innovative Industrial Properties, Inc. Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against IIPR

(NYSE:IIPR), SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Innovative Industrial Properties, Inc. (NYSE: IIPR) securities between February 27, 2024 and December 19, 2024. IIPR is an internally managed real estate investment trust

Shareholder Alert: Robbins LLP Informs Stockholders of the Block, Inc. Class Action

(NYSE:SQ), SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Block, Inc. (NYSE: SQ) Class A common stock between February 26, 2020 and April 30, 2024. Block is a financial technology conglomerate. For more

Scroll to Top